FGF2 and cancer: Besides, as FGF2 is an in vivo modulator of matrix metallopeptidase 13 (MMP-13) expression in malignant tumors [17], a significant decrease in the level of MMP-13 protein was also observed in miR-195 overexpressing cells (Figure 7(a)).